Back to Farther Finance Advisors, LLC Farther Finance Advisors, LLC

VRAXVRAX
4 quarters

Position history for Farther Finance Advisors, LLCFarther Finance Advisors, LLC's holdings in VIRAX BIOLABS GROUP LTD

No. Farther Finance Advisors exited its VRAX (Virax Biolabs Group) position in Q2 2026. Its Q1 2026 13F listed 21 shares worth $4. Farther Finance Advisors first reported VRAX in Q3 2025 and held it in 3 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$13

Total Shares Change

-21

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$2.94
0
2026-Q1
Unchanged
21
0.0%
$40.0%$0.20
0
2025-Q4
Unchanged
21
0.0%
$70.0%$0.35
0
2025-Q3
New
21
-
$130.0%$0.60
17

Other major holders of VRAX: Schonfeld Strategic Advisors LLC, Legal & General Group Plc, UBS Group AG, Virtu Financial LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used